- Filed
- Mar 27, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Dec 31, 2024 | 169.13M sh |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $273.51M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $300.38M |
| Current Assets | FY 2024 · Dec 31, 2023 | $520.46M |
| Total Assets | FY 2024 · Dec 31, 2023 | $1.2B |
| Shares Diluted | FY 2024 · Dec 31, 2022 | 157.69M sh |
| Capex | FY 2024 · Dec 31, 2022 | $8.35M |
| Operating Cash Flow restated | FY 2024 · Dec 31, 2022 | $89.33M |
| Cash And Equivalents | FY 2024 · Dec 31, 2022 | $165.03M |
| Eps Diluted | FY 2024 · Dec 31, 2022 | −$1.24 |
| Eps Basic | FY 2024 · Dec 31, 2022 | −$1.24 |
| Sga Expense | FY 2024 · Dec 31, 2022 | $60.2M |
| Rd Expense | FY 2024 · Dec 31, 2022 | $81.21M |
| Net Income | FY 2024 · Dec 31, 2022 | −$195.41M |
| Operating Income | FY 2024 · Dec 31, 2022 | −$189.32M |
| Gross Profit | FY 2024 · Dec 31, 2022 | $158.18M |
| Cost Of Revenue | FY 2024 · Dec 31, 2022 | $250.87M |
| Revenue | FY 2024 · Dec 31, 2022 | $409.05M |
| Stockholders Equity | FY 2024 · Dec 31, 2021 | $695.75M |